The new findings should help public health officials more quickly and accurately determine which strains to include in the annual flu vaccine.
The study, supported in part by the National Institutes of Health (NIH), appears online in advance of print in the journal Nature.
The researchers analyzed full gene sequences of seasonal influenza virus samples collected from the world’s temperate regions north and south of the equator. Their data comprised full genetic sequences of 1,302 isolates of influenza A virus collected over 12 years from New Zealand and New York state.
By quantifying the degree of genetic diversity among the strains’ subtypes, gene segments and geographic locations, the researchers were able to detect patterns indicating that virus strains do not persist from one flu season to the next in the temperate regions. Therefore, the researchers deduced, new flu strains emerge annually from the tropics.
The international team of researchers included Jeffery K. Taubenberger, M.D., Ph.D., of the National Institute of Allergy and Infectious Diseases, NIH; Cecile Viboud, Ph.D., of NIH’s Fogarty International Center; and Edward C. Holmes, Ph.D., of Pennsylvania State University, who received funding from the National Institute of General Medical Sciences, NIH. The gene sequence information is stored in an NIAID-supported and publicly accessible database, the Influenza Genome Sequencing Project http://www3.niaid.nih.gov/research/resources/mscs/Influenza/.
ARTICLE: A Rambaut et al. The genomic and epidemiological dynamics of human influenza A virus. Nature DOI: 10.1038/nature06945 (2008).
WHO: NIAID Director Anthony S. Fauci, M.D., is available to comment. Jeffery K. Taubenberger, M.D., Ph.D., Laboratory of Infectious Diseases, NIAID, is also available.
CONTACT: To schedule interviews, contact Anne A. Oplinger in the NIAID Office of Communications and Government Relations at 301-402-1663 or email@example.com.
NIAID is a component of the National Institutes of Health. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on basic immunology, transplantation and immune-related disorders, including autoimmune diseases, asthma and allergies.
The National Institutes of Health (NIH)--The Nation's Medical Research Agency--includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases.
News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.
Drone vs. truck deliveries: Which create less carbon pollution?
31.05.2017 | University of Washington
New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)
An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.
Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...
Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.
Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...
Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.
As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...
Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.
With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...
Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine
Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...
19.06.2017 | Event News
13.06.2017 | Event News
13.06.2017 | Event News
23.06.2017 | Physics and Astronomy
23.06.2017 | Physics and Astronomy
23.06.2017 | Information Technology